DE:AWY0 Stock Latest News
Company AnnouncementsFDA Clears Vanderbilt Trial of Percheron’s HMBD-002 in AML58m ago
Company AnnouncementsPercheron Therapeutics Wins ASX Waiver to Quote PERAQ Options After Capital Raising2d ago
Company AnnouncementsPercheron bolsters cancer pipeline with new trial, Invion tie-up and fresh leadership1w ago
Company AnnouncementsInvion and Percheron Launch Preclinical Cancer Combo Study with Photosoft and VISTA Antibody1w ago
Company AnnouncementsPercheron and Invion Launch Preclinical Cancer Combo Study1w ago
Company AnnouncementsPercheron Therapeutics seeks ASX quotation for major new share issue2w agoCompany AnnouncementsPercheron Therapeutics Issues 75 Million Unquoted Performance Stock Units3w ago
Company AnnouncementsPercheron Therapeutics Wins Strong Shareholder Backing at 2026 AGM3w ago
Company AnnouncementsPercheron advances HMBD-002 program as transition year reshapes pipeline3w ago
Company AnnouncementsPercheron Therapeutics Plans Issue of 75 Million Performance Restricted Stock Units3w ago
Company AnnouncementsPercheron Therapeutics Names New CEO to Drive Oncology Strategy and Investor Outreach4w ago
Company AnnouncementsPercheron Therapeutics Issues 300 Million New Shares to Institutional and Sophisticated Investors1M agoCompany AnnouncementsPercheron Therapeutics Sets Hybrid Annual General Meeting for October 20261M ago
Company AnnouncementsPercheron updates investors as Vanderbilt trial advances HMBD-0022M ago
Company AnnouncementsPercheron Therapeutics Plans Issue of 50 Million Quoted Options2M ago- Company AnnouncementsPercheron Therapeutics Plans Major Share and Option Issuance on ASX2M ago
- Company AnnouncementsPercheron Therapeutics Plans Major Share and Option Issue on ASX2M ago
Company AnnouncementsPercheron Therapeutics Details Equity Interests of New Director Deborah Ambrosini2M ago